Publikationen

Bücher
Putzki N: Treatment of Multiple Sclerosis. unimed science. Bremen :
Unimed, 2009.- ISBN 978-3-8374-2093-7

Putzki N: 1000 Fragen zur Facharztprüfung Neurologie (1000 questions to prepare medical board examination in neurology). Stuttgart : Thieme, 2007

Putzki N: Guidelines of the German Neurological Society for diagnostic and treatment of neurological diseases : DGN Guidelines. DGN Leitlinien. Stuttgart : Thieme, 2005

Putzki N: Langzeittherapie der MS mit Inferon-beta 1a i. m.
(Long term therapy of MS with IFN-beta 1a i.m.) : ME, 2004
 
Wissenschaftliche Artikel
Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener H C, Katsarava Z. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:262-7.

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:713-20.

Yaldizli O, Baumberger P, Putzki N. (Natalizumab and atypical naevi: Comments on the pharmacovigilance note by J.-L. Schmutz et al.).Annales de dermatologie et de vénéréologie 2009; 136:450-1.

Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn B, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;.

Putzki N, Kollia K, Woods S, Igwe E, Diener H C, Limmroth V. Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6.

Putzki N. Natalizumab in the treatment of multiple sclerosis. Therapeutic Adv Neurol 2009; 2:115-128.

Yaldizli O, Kumar M, Vago S, Kreuzfelder E, Limmroth V, Putzki N. Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis. European neurology 2009; 62:321-326.

Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn J M, Kraff O, Ladd M E, Forsting M, Wanke I. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR. American journal of neuroradiology 2009; 30:699-702.

Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener H C, Limmroth V. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study. European neurology 2009; 61:27-32.

Putzki N, Yaldizli O, Tettenborn B, Diener H C. Multiple sclerosis associated fatigue during natalizumab treatment. Journal of the neurological sciences 2009;.

Putzki N, Katsarava Z, Vago S, Diener H C, Limmroth V. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. European neurology 2008; 59:136-42.

Putzki N, Graf K, Stude P, Diener H C, Maschke M. Habituation of the auditory startle response in cervical dystonia and Parkinson's disease. European neurology 2008; 59:172-8.

Obermann M, Yaldizli O, de Greiff A, Konczak J, Lachenmayer M L, Tumczak F, Buhl A R, Putzki N, Vollmer-Haase J, Gizewski E R, Diener H C, Maschke M. Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia. European journal of neurology : the official journal of the European Federation of Neurological Societies 2008; 15:831-8.

Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. European journal of neurology : the official journal of the European Federation of Neurological Societies 2007; 14:e12-3.

Limmroth V, Malessa R, Zettl U K, Koehler J, Japp G, Haller P, Elias W, Obhof W, Viehöver A, Meier U, Brosig A, Hasford J, Putzki N, Kalski G, Wernsdörfer C, QUASIMS Study Group . Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. Journal of neurology 2007; 254:67-77.

Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener H C, Limmroth V. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 2006; 12:363-6.

Putzki N, Stude P, Konczak J, Graf K, Diener H C, Maschke M. Kinesthesia is impaired in focal dystonia. Movement disorders : official journal of the Movement Disorder Society 2006; 21:754-60.

Kumar M, Putzki N, Limmroth V, Remus R, Lindemann M, Knop D, Mueller N, Hardt C, Kreuzfelder E, Grosse-Wilde H. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. Journal of neuroimmunology 2006; 180:178-84.

Putzki N, Nirkko A, Diener H C. Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome?. Cephalalgia : an international journal of headache 2005; 25:395-7.

Limmroth V, Putzki N. High-dose, frequently administered interferon beta. Journal of the neurological sciences 2005; 231:95-6; author reply 97-9.

Kowacs F, Giffin N J, Putzki N, Goadsby P J, Kaube H. Nociceptive-specific blink reflex and glyceryl trinitrate infusion in healthy volunteers. European journal of neurology : the official journal of the European Federation of Neurological Societies 2003; 10:295-9.

Putzki N, Maschke M, Drepper J, Diener H C, Timmann D. Effect of functional NMDA-antagonist flupirtine on automatic postural responses in Parkinson's disease. Journal of neurology 2002; 249:824-8.